These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 5406928)

  • 41. [Problems in ambulatory drug therapy. 4. Studies and human pharmacological aspects on ambulatory drug therapy of gastritis].
    Lederer R; Walther H; Meyer FP
    Z Arztl Fortbild (Jena); 1973 Jul; 67(13):642-50. PubMed ID: 4148959
    [No Abstract]   [Full Text] [Related]  

  • 42. [ON THE CONTROL OF AKINESIA AND OTHER EXTRAPYRAMIDAL MOTOR DISORDERS WITH L-DOPA (L-DIHYDROXYPHENYLALANINE)].
    HIRSCHMANN J; MAYER K
    Dtsch Med Wochenschr; 1964 Oct; 89():1877-80. PubMed ID: 14211843
    [No Abstract]   [Full Text] [Related]  

  • 43. The prophylaxis of carbon tetrachloride hepatotoxicity by total belladonna alkaloids.
    Soliman MA; Elwi AM; Kamel SH; el-Kateb H
    J Egypt Med Assoc; 1966; 49(1):59-69. PubMed ID: 5959536
    [No Abstract]   [Full Text] [Related]  

  • 44. Extractum belladonnae in epilepsy therapy. (A preliminary study).
    Sie PG
    Paediatr Indones; 1965; 5(3):47-54. PubMed ID: 5873754
    [No Abstract]   [Full Text] [Related]  

  • 45. [Ulfon in the treatment of gastroduodenal ulcer].
    Tournerie J
    J Med Bord; 1965 May; 142(5):853-8. PubMed ID: 5830454
    [No Abstract]   [Full Text] [Related]  

  • 46. [Present-day possibilities of relieving post-neuroleptic extrapyramidal symptoms].
    Wasik A
    Psychiatr Pol; 1973; 7(1):51-6. PubMed ID: 4715833
    [No Abstract]   [Full Text] [Related]  

  • 47. Troxonium tosylate in the treatment of drug-induced extrapyramidal manifestations.
    Koh CV; Ananth JV; Ban TA; Lehmann HE
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):289-91. PubMed ID: 4931413
    [No Abstract]   [Full Text] [Related]  

  • 48. [Controlled verification of the usefulness of Ketoscilium in gastroenterology].
    Alberto S; Pinna G; Frigerio G
    Minerva Med; 1971 Feb; 62(17):852-6. PubMed ID: 5551774
    [No Abstract]   [Full Text] [Related]  

  • 49. "Rational hope" in the early treatment of Parkinson's disease.
    Sourkes TL
    Can J Physiol Pharmacol; 1999 Jun; 77(6):375-82. PubMed ID: 10537223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [On the treatment of Parkinson's syndrome with monoamine oxidase inhibitors alone and in combination with L-dopa].
    Gerstenbrand F; Prosenz P
    Praxis; 1965 Nov; 54(46):1373-7. PubMed ID: 5899418
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical diagnosis and therapy of chronic stomach diseases].
    Hadzijahić H; Kesić V; Bratović L; Ljubojević S; Gribajcević M
    Med Arh; 1976; 30(6):371-5. PubMed ID: 1026833
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of early Parkinson's disease. Part 1.
    Simuni T; Lyons KE; Pahwa R; Hauser RA; Comella C; Elmer L; Weintraub D
    Eur Neurol; 2009; 61(4):193-205. PubMed ID: 19176960
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical experimentation with a new anti-vertigo and anti-nausea drug: R.306].
    Bossut Y; Deguine C; Decroix G
    Lille Med; 1970 Nov; ():Suppl 6:1353+. PubMed ID: 5502910
    [No Abstract]   [Full Text] [Related]  

  • 54. Studies on peptic ulcer disease with special reference to the effect of l-hyoscyamine.
    Walan A
    Acta Med Scand Suppl; 1970; 516():1-57. PubMed ID: 5293126
    [No Abstract]   [Full Text] [Related]  

  • 55. [Disorders of vegetative regulation. Symptoms and therapeutic possibilities].
    Ohlenschläger G
    Med Klin; 1972 Dec; 67(50):1658-65. PubMed ID: 4661508
    [No Abstract]   [Full Text] [Related]  

  • 56. An open study with reversible MAO-A inhibitors in complicated Parkinson's disease.
    Ruggieri S; Fabbrini G; Bramante L; DePandis F; Stocchi F; Barbanti P; Vacca L; Manfredi M
    Adv Neurol; 1996; 69():595-8. PubMed ID: 8615185
    [No Abstract]   [Full Text] [Related]  

  • 57. [Experimentation with Aparadoxal in pediatrics].
    Orsini A; Perrimond H; Spriet A
    Rev Neuropsychiatr Infant; 1970 Dec; 18(12):967-71. PubMed ID: 5510079
    [No Abstract]   [Full Text] [Related]  

  • 58. [Features of medical therapy of Parkinson's syndrome].
    BIRKMAYER W; MENTASTI M
    Wien Klin Wochenschr; 1962 Oct; 74():700-2. PubMed ID: 13971141
    [No Abstract]   [Full Text] [Related]  

  • 59. [Experiences with the use of 1-nortricyclenyl-1-phenyl-3-piperidino-1-propanol HC1 (isomer mixture)--P 259--VEB Fahlberg List Magdeburg in the treatment of severe disorders of the extrapyramidal motor system].
    Lange E; Seidel K; Niedermeyer K; Poppe W
    Dtsch Gesundheitsw; 1966 Feb; 21(8):380-3. PubMed ID: 5968216
    [No Abstract]   [Full Text] [Related]  

  • 60. [Oral therapy of nasal sinus diseases with a new drug compound].
    Ganança MM
    Hospital (Rio J); 1967 Jun; 71(6):1645-8. PubMed ID: 5304517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.